Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " October 07, 2013":" November 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
22 Completed Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Dapivirine Vaginal Ring
23 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density
Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir, 50mg every 24 hours;   Drug: Protease Inhibitor/ritonavir
24 Completed A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Condition: HIV
Interventions: Drug: 1% vaginally applied tenofovir gel;   Drug: Tenofovir film- 10mg;   Drug: Tenofovir Film-40 mg;   Other: HEC Placebo Gel;   Other: Placebo Vaginal Film
25 Active, not recruiting Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.
Condition: HIV
Intervention: Drug: emtricitabine / tenofovir 200/300 mg
26 Unknown  Modified Directly Observed Antiretroviral Therapy
Condition: HIV
Intervention: Other: Home visits
27 Completed Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).
Conditions: HIV;   Depression
Interventions: Drug: raltegravir;   Drug: citalopram
28 Enrolling by invitation Botswana Combination Prevention Project
Condition: HIV
Interventions: Other: Combination Prevention;   Other: Enhanced Care
29 Recruiting Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)
Conditions: Substance Use Disorders;   HIV
30 Active, not recruiting Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone
Condition: HIV+
Interventions: Drug: Oral naltrexone;   Drug: Naltrexone implant
31 Completed Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients
Condition: HIV-HCV Co-infected Patients
Intervention: Genetic: blood samples
32 Completed
Has Results
A Trial of Radiofrequency Ablation for Anal Intraepithelial Neopplasia Using the HALO Ablation System
Condition: HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-grade Squamous Intraepithelial Lesions.
Intervention: Device: Radiofrequency Ablation (RFA) using the HALO Ablation System
33 Unknown  Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
Condition: Drug Interaction
Intervention: Drug: Efavirenz
34 Completed Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
Conditions: Latent Tuberculosis;   Latent Tuberculosis Bacteriology and Histology Unknown
Intervention: Biological: Aeras-456
35 Completed
Has Results
Rapid, Minimally-invasive Voluntary Adult Male Circumcision
Condition: Circumcision
Interventions: Procedure: Surgical Control;   Procedure: Unicirc with tissue adhesive
36 Completed Multi-Level HIV Prevention for Pregnant Drug Abusers
Condition: Substance Related Disorders
Intervention: Behavioral: Enhanced Behavioral Skills Training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years